Related references
Note: Only part of the references are listed.Compatibility of intravitreally applied epidermal growth factor and amphiregulin
Mukharram M. Bikbov et al.
INTERNATIONAL OPHTHALMOLOGY (2021)
Intraocular epidermal growth factor concentration, axial length, and high axial myopia
Jost B. Jonas et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2021)
Continued Increase of Axial Length and Its Risk Factors in Adults With High Myopia
Ran Du et al.
JAMA OPHTHALMOLOGY (2021)
Longitudinal changes in axial length in high myopia: a 4-year prospective study
Min Woo Lee et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2020)
Blockade of epidermal growth factor and its receptor and axial elongation in experimental myopia
Li Dong et al.
FASEB JOURNAL (2020)
Amphiregulin and ocular axial length
Li Dong et al.
ACTA OPHTHALMOLOGICA (2019)
Progression of Myopic Maculopathy during 18-Year Follow-up
Yuxin Fang et al.
OPHTHALMOLOGY (2018)
BRUCH MEMBRANE AND THE MECHANISM OF MYOPIZATION A New Theory
Jost B. Jonas et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2017)
Amphiregulin Antibody and Reduction of Axial Elongation in Experimental Myopia
Wen Jun Jiang et al.
EBIOMEDICINE (2017)
Long-Term Changes in Axial Length in Adult Eyes with Pathologic Myopia
Natsuko Saka et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Epidermal growth factor receptor targeting in cancer
John Mendelsohn et al.
SEMINARS IN ONCOLOGY (2006)
Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors
S Segaert et al.
ANNALS OF ONCOLOGY (2005)
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
D Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
